299 related articles for article (PubMed ID: 31484636)
1. Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo.
McMahon TJ; Shan S; Riccio DA; Batchvarova M; Zhu H; Telen MJ; Zennadi R
Blood Adv; 2019 Sep; 3(17):2586-2597. PubMed ID: 31484636
[TBL] [Abstract][Full Text] [Related]
2. Disrupting the vicious cycle created by NOX activation in sickle erythrocytes exposed to hypoxia/reoxygenation prevents adhesion and vasoocclusion.
MacKinney A; Woska E; Spasojevic I; Batinic-Haberle I; Zennadi R
Redox Biol; 2019 Jul; 25():101097. PubMed ID: 30661992
[TBL] [Abstract][Full Text] [Related]
3. MEK inhibitors, novel anti-adhesive molecules, reduce sickle red blood cell adhesion in vitro and in vivo, and vasoocclusion in vivo.
Zennadi R
PLoS One; 2014; 9(10):e110306. PubMed ID: 25330306
[TBL] [Abstract][Full Text] [Related]
4. Gαs proteins activate p72(Syk) and p60-c-Src tyrosine kinases to mediate sickle red blood cell adhesion to endothelium via LW-αvβ3 and CD44-CD44 interactions.
Chiou E; Zennadi R
Int J Biochem Cell Biol; 2015 Aug; 65():40-51. PubMed ID: 26007235
[TBL] [Abstract][Full Text] [Related]
5. Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.
Zennadi R; Moeller BJ; Whalen EJ; Batchvarova M; Xu K; Shan S; Delahunty M; Dewhirst MW; Telen MJ
Blood; 2007 Oct; 110(7):2708-17. PubMed ID: 17609430
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell vaso-occlusion.
Chiang EY; Frenette PS
Hematol Oncol Clin North Am; 2005 Oct; 19(5):771-84, v. PubMed ID: 16214643
[TBL] [Abstract][Full Text] [Related]
7. Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.
Liu Y; Zhong H; Bao W; Mendelson A; An X; Shi P; Chou ST; Manwani D; Yazdanbakhsh K
Blood; 2019 Aug; 134(7):579-590. PubMed ID: 31076443
[TBL] [Abstract][Full Text] [Related]
8. Renitrosylation of banked human red blood cells improves deformability and reduces adhesivity.
Riccio DA; Zhu H; Foster MW; Huang B; Hofmann CL; Palmer GM; McMahon TJ
Transfusion; 2015 Oct; 55(10):2452-63. PubMed ID: 26098062
[TBL] [Abstract][Full Text] [Related]
9. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
Zhao Y; Schwartz EA; Palmer GM; Zennadi R
FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
[TBL] [Abstract][Full Text] [Related]
10. Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo.
Thamilarasan M; Estupinan R; Batinic-Haberle I; Zennadi R
Blood Adv; 2020 Jun; 4(11):2372-2386. PubMed ID: 32479589
[TBL] [Abstract][Full Text] [Related]
11. Effect of propranolol as antiadhesive therapy in sickle cell disease.
De Castro LM; Zennadi R; Jonassaint JC; Batchvarova M; Telen MJ
Clin Transl Sci; 2012 Dec; 5(6):437-44. PubMed ID: 23253664
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte adhesion in sickle cell disease.
Parise LV; Telen MJ
Curr Hematol Rep; 2003 Mar; 2(2):102-8. PubMed ID: 12901140
[TBL] [Abstract][Full Text] [Related]
13. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
[TBL] [Abstract][Full Text] [Related]
14. Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions.
Zennadi R; Hines PC; De Castro LM; Cartron JP; Parise LV; Telen MJ
Blood; 2004 Dec; 104(12):3774-81. PubMed ID: 15308566
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium.
Haynes J; Obiako B; Hester RB; Baliga BS; Stevens T
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H379-85. PubMed ID: 17993595
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion.
Brittain HA; Eckman JR; Swerlick RA; Howard RJ; Wick TM
Blood; 1993 Apr; 81(8):2137-43. PubMed ID: 8471771
[TBL] [Abstract][Full Text] [Related]
17. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
Finnegan EM; Turhan A; Golan DE; Barabino GA
Am J Hematol; 2007 Apr; 82(4):266-75. PubMed ID: 17094094
[TBL] [Abstract][Full Text] [Related]
18. Rheological studies of erythrocyte-endothelial cell interactions in sickle cell disease.
Barabino GA; McIntire LV; Eskin SG; Sears DA; Udden M
Prog Clin Biol Res; 1987; 240():113-27. PubMed ID: 3615482
[TBL] [Abstract][Full Text] [Related]
19. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
[TBL] [Abstract][Full Text] [Related]
20. Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.
Telen MJ; Batchvarova M; Shan S; Bovee-Geurts PH; Zennadi R; Leitgeb A; Brock R; Lindgren M
Br J Haematol; 2016 Dec; 175(5):935-948. PubMed ID: 27549988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
